The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Here's a roundup of top developments in the biotech space over the last 24 hours.
Tenaya Therapeutics Late Yesterday Announced Co. Will Present Preclinical Data On Its Gene Therapy Programs At The ESGCT 28Th Annual Congress
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will
Tenaya Therapeutics, Eliem Therapeutics, Adagio Therapeutics Shares Quiet Following Recent TipRanks Article ‘Buy These 3 New Stocks Before They Jump Over 60%, Say Analysts’
https://www.tipranks.com/news/article/buy-these-3-new-stocks-before-they-jump-over-60-say-analysts/
48 Biggest Movers From Friday
Gainers
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Tenaya Therapeutics Q2 EPS $(13.26) Down From $(9.21) YoY
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(13.26) per share. This is a 43.97 percent decrease over losses of $(9.21) per share from the same period last year.
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 26)